2012
DOI: 10.1161/circoutcomes.112.965046
|View full text |Cite
|
Sign up to set email alerts
|

Glucose, Blood Pressure, and Cardiovascular Risk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 21 publications
0
3
0
Order By: Relevance
“…Whether this hyperglycaemia is severe enough to induce glucotoxicity and worsen the outcomes of the comorbidities in individuals with diabetes/ prediabetic state when Carvedilol is used needs to be analyzed. The findings of this study also highlights the need to revisit the notion that Carvedilol improves the co-morbidities in diabetics [17] by beneficial effect on blood glucose levels. Though the beneficial effects of Carvedilol when used in diabetics for various indications is not questioned [17], the notion that such a beneficial effect is due to improvement in glucose tolerance, is questioned by the findings of this study.…”
Section: Discussionmentioning
confidence: 73%
See 2 more Smart Citations
“…Whether this hyperglycaemia is severe enough to induce glucotoxicity and worsen the outcomes of the comorbidities in individuals with diabetes/ prediabetic state when Carvedilol is used needs to be analyzed. The findings of this study also highlights the need to revisit the notion that Carvedilol improves the co-morbidities in diabetics [17] by beneficial effect on blood glucose levels. Though the beneficial effects of Carvedilol when used in diabetics for various indications is not questioned [17], the notion that such a beneficial effect is due to improvement in glucose tolerance, is questioned by the findings of this study.…”
Section: Discussionmentioning
confidence: 73%
“…(β2 blocakade mediated) [20] which need to be explored in future studies. This also contends with the hypoglycaemic effects of Carvedilol reported in some studies [15,16,17]. Whether this hyperglycaemia is severe enough to induce glucotoxicity and worsen the outcomes of the comorbidities in individuals with diabetes/ prediabetic state when Carvedilol is used needs to be analyzed.…”
Section: Discussionmentioning
confidence: 75%
See 1 more Smart Citation